These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 32762989)
1. Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments. Augustovski F; Belizán M; Gibbons L; Reyes N; Stolk E; Craig BM; Tejada RA Value Health; 2020 Jul; 23(7):880-888. PubMed ID: 32762989 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K Value Health; 2016; 19(5):648-54. PubMed ID: 27565282 [TBL] [Abstract][Full Text] [Related]
3. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set. Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730 [TBL] [Abstract][Full Text] [Related]
4. United States Valuation of EQ-5D-5L Health States Using an International Protocol. Pickard AS; Law EH; Jiang R; Pullenayegum E; Shaw JW; Xie F; Oppe M; Boye KS; Chapman RH; Gong CL; Balch A; Busschbach JJV Value Health; 2019 Aug; 22(8):931-941. PubMed ID: 31426935 [TBL] [Abstract][Full Text] [Related]
5. Dutch Tariff for the Five-Level Version of EQ-5D. M Versteegh M; M Vermeulen K; M A A Evers S; de Wit GA; Prenger R; A Stolk E Value Health; 2016 Jun; 19(4):343-52. PubMed ID: 27325326 [TBL] [Abstract][Full Text] [Related]
6. Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study. Ludwig K; von der Schulenburg JG; Greiner W Health Qual Life Outcomes; 2017 Feb; 15(1):39. PubMed ID: 28219389 [TBL] [Abstract][Full Text] [Related]
7. Preference heterogeneity in health valuation: a latent class analysis of the Peru EQ-5D-5L values. Karim S; Craig BM; Tejada RA; Augustovski F Health Qual Life Outcomes; 2023 Jan; 21(1):1. PubMed ID: 36593473 [TBL] [Abstract][Full Text] [Related]
8. The EQ-5D-5L valuation study for Trinidad and Tobago. Bailey H; Jonker MF; Pullenayegum E; Rencz F; Roudijk B Health Qual Life Outcomes; 2024 Jul; 22(1):51. PubMed ID: 38956543 [TBL] [Abstract][Full Text] [Related]
9. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments. Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626 [TBL] [Abstract][Full Text] [Related]
10. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets. Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577 [TBL] [Abstract][Full Text] [Related]
11. A Direct Comparison Between Discrete Choice With Duration and Composite Time Trade-Off Methods: Do They Produce Similar Results? Roudijk B; Jonker MF; Bailey H; Pullenayegum E Value Health; 2024 Sep; 27(9):1280-1288. PubMed ID: 38843979 [TBL] [Abstract][Full Text] [Related]
12. Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study. Al-Jedai A; Almudaiheem H; Al-Salamah T; Aldosari M; Almutairi AR; Almogbel Y; AlRuthia Y; Althemery AU; Alluhidan M; Roudijk B; Purba FD; Awad N; O'jeil R Value Health; 2024 May; 27(5):552-561. PubMed ID: 38342365 [TBL] [Abstract][Full Text] [Related]
13. A national survey of Iranian general population to estimate a value set for the EQ-5D-5L. Afshari S; Daroudi R; Goudarzi R; Mahboub-Ahari A; Yaseri M; Sari AA; Ameri H; Bahariniya S; Oliaei-Manesh A; Kalavani K; Zare Z; Hasannezhad E; Mirzaei M; Amiri Z Qual Life Res; 2023 Jul; 32(7):2079-2087. PubMed ID: 36897530 [TBL] [Abstract][Full Text] [Related]
14. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L. Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267 [TBL] [Abstract][Full Text] [Related]
15. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values. Fitriana TS; Roudijk B; Purba FD; Busschbach JJV; Stolk E Pharmacoeconomics; 2022 Dec; 40(Suppl 2):157-167. PubMed ID: 36348155 [TBL] [Abstract][Full Text] [Related]
16. The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data. Jensen CE; Sørensen SS; Gudex C; Jensen MB; Pedersen KM; Ehlers LH Appl Health Econ Health Policy; 2021 Jul; 19(4):579-591. PubMed ID: 33527304 [TBL] [Abstract][Full Text] [Related]
17. An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. Finch AP; Meregaglia M; Ciani O; Roudijk B; Jommi C Soc Sci Med; 2022 Jan; 292():114519. PubMed ID: 34736804 [TBL] [Abstract][Full Text] [Related]
18. The EQ-5D-5L Valuation study in Thailand. Pattanaphesaj J; Thavorncharoensap M; Ramos-Goñi JM; Tongsiri S; Ingsrisawang L; Teerawattananon Y Expert Rev Pharmacoecon Outcomes Res; 2018 Oct; 18(5):551-558. PubMed ID: 29958008 [TBL] [Abstract][Full Text] [Related]
19. A Methodological Study to Compare Alternative Modes of Administration With Value EQ-5D Using Preference-Elicitation Techniques. Hill SR; Gibson A; Oluboyede Y; Longworth L; Bennett B; Shaw JW Value Health; 2024 Jun; 27(6):784-793. PubMed ID: 38467189 [TBL] [Abstract][Full Text] [Related]
20. Valuation Survey of EQ-5D-Y Based on the International Common Protocol: Development of a Value Set in Japan. Shiroiwa T; Ikeda S; Noto S; Fukuda T; Stolk E Med Decis Making; 2021 Jul; 41(5):597-606. PubMed ID: 33754886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]